The U.S. Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insuli ...

Merilog is expected to be available in July 2025, and Sanofi will provide Merilog to patients for $35 or less for a 30-day ...

First-ever rapid-acting insulin. This approval extends to a 3-milliliter single-patient-use prefilled pen and a 10-milliliter ...

Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.

The biosimilars reach the US market as the US insulin space has seen seismic changes in the last few years, with a clamour of ...

According to the FDA, the medication quickly helps to lower mealtime blood sugar spikes to improve control of blood sugar in ...

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

Soliqua 100/33 (insulin glargine/lixisenatide ... Keep reading to learn more about Soliqua 100/33’s dosage, side effects, uses, and more. Soliqua 100/33 comes as a liquid solution inside ...

The prescribed dosage for fluoxetine may depend on a person’s individual treatment plan. Other factors, including your specific diagnosis, body weight, and medical history, may affect your ...

A brief summary - strong Buy, Buy, strong sell, sell or neutral signals for the Bnp Paribas Lantus Fic Fi Multimercado Crédito Privado fund. Access detailed technical analysis through moving averages ...

Lantus, Toujeo, Semglee, Rezvoglar (insulin glargine) Your healthcare provider will tell you how much insulin you need to draw up from the vial for each dose. The insulin is injected through a needle.

Progression-free and overall survival do not differ for patients receiving full-dose, lowered-dose dexamethasone throughout induction. HealthDay News — For patients with newly diagnosed multiple ...